Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Scientific articles 1 May 2024 Blood transfusion in the care of patients with visceral leishmaniasis: a review of practices in therapeutic efficacy studies Transactions of The Royal Society of Tropical Medicine and Hygiene
In the media 29 Apr 2024 Comienza con incertidumbre última ronda negociadora para un tratado global antipandemias EFE
In the media 28 Apr 2024 Geplantes Pandemieabkommen: Was es regelt und wo es hakt Deutsche Presse-Agentur
Statements 25 Apr 2024 DNDi comments on WHO Pandemic Agreement – Recommendations for Article 9: Research and Development
In the media 1 May 2024 DNDi receives grant to develop treatments for NTDs The Lancet Infectious Diseases
In the media 23 Apr 2024 دخول علاج فموي جديد وواعد وصديق لمرضى الكالازار المرحلة الثانية من التطوير السريري في إثيوبيا Al Jazeera
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Publications 29 Sep 2022 The Science Explained: Evaluating an alternative treatment regimen for visceral leishmaniasis in Eastern Africa
Publications 23 Jun 2022 The Opportunity to Eliminate Hepatitis C through Alternative Financing Mechanisms
Publications 20 Jun 2022 Countermeasure R&D: Global norms for financing risk reduction, resilience & equity
Publications 8 Jun 2022 The Science Explained: Evaluating new treatment regimens for visceral leishmaniasis in people living with HIV in India and Ethiopia